Functional characterization of melanocortin-3 receptor variants identify a loss-of-function mutation involving an amino acid critical for g protein-coupled receptor activation

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 8, 2004, Pages 3936-3942

  Tao, Ya Xiong ^a   Segaloff, Deborah L ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; MELANOCORTIN 3 RECEPTOR; VALINE;

ARTICLE; CODON; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN VARIANT; SIGNAL TRANSDUCTION; WILD TYPE;

ASPARAGINE; CELL LINE; CODON; GENE EXPRESSION REGULATION; HUMANS; ISOLEUCINE; LYSINE; MUTATION; RECEPTOR, MELANOCORTIN, TYPE 3; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, LH; THREONINE; VALINE; VARIATION (GENETICS);

EID: 4043093705     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-0367     Document Type: Article

References (48)

1. Smith AI, Funder JW 1988 Proopiomelanocortin processing in the pituitary, central nervous system, and peripheral tissues. Endocr Rev 9:159-179
2. Gantz I, Fong TM 2003 The melanocortin system. Am J Physiol Endocrinol Metab 284:E468-E474
3. Gantz I, Konda Y, Tashiro T, Shimoto Y, Miwa H, Munzert G, Watson SJ, DelValle J, Yamada T 1993 Molecular cloning of a novel melanocortin receptor. J Biol Chem 268:8246-8250
4. Roselli-Rehfuss L, Mountjoy KG, Robbins LS, Mortrud MT, Low MJ, Tatro JB, Entwistle ML, Simerly RB, Cone RD 1993 Identification of a receptor for γ melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc Natl Acad Sci USA 90:8856-8860
5. Gantz I, Tashiro T, Barcroft C, Konda Y, Shimoto Y, Miwa H, Glover T, Munzert G, Yamada T 1993 Localization of the genes encoding the melanocortin-2 (adrenocorticotropic hormone) and melanocortin-3 receptors to chromosomes 18p11.2 and 20q13.2-q13.3 by fluorescence in situ hybridization. Genomics 18:166-167
6. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F 1997 Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88:131-141
7. Chen AS, Marsh DJ, Trumbauer ME, Frazier EG, Guan XM, Yu H, Rosenblum CI, Vongs A, Feng Y, Cao L, Metzger JM, Strack AM, Camacho RE, Mellin TN, Nunes CN, Min W, Fisher J, Gopal-Truter S, MacIntyre DE, Chen HY, Van der Ploeg LH 2000 Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet 26:97-102
8. Butler AA, Kesterson RA, Khong K, Cullen MJ, Pelleymounter MA, Dekoning J, Baetscher M, Cone RD 2000 A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 141: 3518-3521
9. Lembertas AV, Perusse L, Chagnon YC, Fisler JS, Warden CH, Purcell-Huynh DA, Dionne FT, Gagnon J, Nadeau A, Lusis AJ, Bouchard C 1997 Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q. J Clin Invest 100:1240-1247
10. Zouali H, Hani EH, Philippi A, Vionnet N, Beckmann JS, Demenais F, Froguel P 1997 A susceptibility locus for early onset noninsulin dependent (type 2) diabetes mellitus maps to chromosome 20q, proximal to the phosphoenolpyruvate carboxykinase gene. Hum Mol Genet 6:1401-1408
11. Ji L, Malecki M, Warram JH, Yang Y, Rich SS, Krolewski AS 1997 New susceptibility locus for NIDDM is localized to human chromosome 20q. Diabetes 46:876-881
12. Bowden DW, Sale M, Howard TD, Qadri A, Spray BJ, Rothschild CB, Akots G, Rich SS, Freedman BI 1997 Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy. Diabetes 46:882-886
13. Ghosh S, Watanabe RM, Hauser ER, Valle T, Magnuson VL, Erdos MR, Langefeld CD, Balow Jr J, Ally DS, Kohtamaki K, Chines P, Birznieks G, Kaleta HS, Musick A, Te C, Tannenbaum J, Eldridge W, Shapiro S, Martin C, Witt A, So A, Chang J, Shurtleff B, Porter R, Kudelko K, Unni A, Segal L, Sharaf R, Blaschak-Harvan J, Eriksson J, Tenkula T, Vidgren G, Ehnholm C, Tuomilehto-Wolf E, Hagopian W, Buchanan TA, Tuomilehto J, Bergman RN, Collins FS, Boehnke M 1999 Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. Proc Natl Acad Sci USA 96:2198-2203
14. Li WD, Joo EJ, Furlong EB, Galvin M, Abel K, Bell CJ, Price RA 2000 Melanocortin 3 receptor (MC3R) gene variants in extremely obese women. Int J Obes Relat Metab Disord 24:206-210
15. Hani EH, Dupont S, Durand E, Dina C, Gallina S, Gantz I, Froguel P 2001 Naturally occurring mutations in the melanocortin receptor 3 gene are not associated with type 2 diabetes mellitus in French Caucasians. J Clin Endocrinol Metab 86:2895-2898
16. Wong J, Love DR, Kyle C, Daniels A, White M, Stewart AW, Schnell AH, Elston RC, Holdaway IM, Mountjoy KG 2002 Melanocortin-3 receptor gene variants in a Maori kindred with obesity and early onset type 2 diabetes. Diabetes Res Clin Pract 58:61-71
17. Schalin-Jantti C, Valli-Jaakola K, Oksanen L, Martelin E, Laitinen K, Krusius T, Mustajoki P, Heikinheimo M, Kontula K 2003 Melanocortin-3-receptor gene variants in morbid obesity. Int J Obes Relat Metab Disord 27:70-74
18. Lee YS, Poh LK, Loke KY 2002 A novel melanocortin 3 receptor gene (MC3R) mutation associated with severe obesity. J Clin Endocrinol Metab 87:1423-1426
19. Ascoli M, Puett D 1978 Gonadotropin binding and stimulation of steroidogenesis in Leydig tumor cells. Proc Natl Acad Sci USA 75:99-102
20. Tao YX, Segaloff DL 2003 Functional characterization of melanocortin-4 receptor mutations associated with childhood obesity. Endocrinology 144:4544-4551
21. Donohoue PA, Tao YX, Collins M, Yeo GSH, O'Rahilly S, Segaloff DL 2003 Deletion of codons 88-92 of the melanocortin-4 receptor gene: a novel deleterious mutation in an obese female. J Clin Endocrinol Metab 88:5841-5845
22. Horton RM, Hunt HD, Ho SN, Pullen JK, Pease LR 1989 Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77:61-68
23. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR 1989 Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59
24. Chen C, Okayama H 1987 High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7:2745-2752
25. Baldwin JM, Schertler GFX, Unger VM 1997 An α-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. J Mol Biol 272:144-164
26. Lubrano-Berthelier C, Durand E, Dubern B, Shapiro A, Dazin P, Weill J, Ferron C, Froguel P, Vaisse C 2003 Intracellular retention is a common characteristic of childhood obesity-associated MC4R mutations. Hum Mol Genet 12:145-153
27. Yeo GS, Lank EJ, Farooqi IS, Keogh J, Challis BG, O'Rahilly S 2003 Mutations in the human melanocortin-4 receptor gene associated with severe familial obesity disrupts receptor function through multiple molecular mechanisms. Hum Mol Genet 12:561-574
28. Nijenhuis WA, Garner KM, VanRozen RJ, Adan RA 2003 Poor cell surface expression of human melanocortin-4 receptor mutations associated with obesity. J Biol Chem 278:22939-22945
29. Min KC, Zvyaga TA, Cypess AM, Sakmar TP 1993 Characterization of mutant rhodopsins responsible for autosomal dominant retinitis pigmentosa. Mutations on the cytoplasmic surface affect transducin activation. J Biol Chem 268:9400-9404
30. Rosenthal W, Antaramian A, Gilbert S, Birnbaumer M 1993 Nephrogenic diabetes insipidus. a V2 vasopressin receptor unable to stimulate adenylyl cyclase. J Biol Chem 268:13030-13033
31. Sadeghi H, Robertson GL, Bichet DG, Innamorati G, Birnbaumer M 1997 Biochemical basis of partial nephrogenic diabetes insipidus phenotypes. Mol Endocrinol 11:1806-1813
32. Puffenberger EG, Hosoda K, Washington SS, Nakao K, deWit D, Yanagisawa M, Chakravart A 1994 A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell 79:1257-1266
33. Tanaka H, Moroi K, Iwai J, Takahashi H, Ohnuma N, Hori S, Takimoto M, Nishiyama M, Masaki T, Yanagisawa M, Sekiya S, Kimura S 1998 Novel mutations of the endothelin B receptor gene in patients with Hirschsprung's disease and their characterization. J Biol Chem 273:11378-111383
34. Hirata T, Kakizuka A, Ushikubi F, Fuse I, Okuma M, Narumiya S 1994 Arg60 to Leu mutation of the human thromboxane A2 receptor in a dominantly inherited bleeding disorder. J Clin Invest 94:1662-1667
35. Frandberg PA, Doufexis M, Kapas S, Chhajlani V 1998 Amino acid residues in third intracellular loop of melanocortin 1 receptor are involved in G-protein coupling. Biochem Mol Biol Int 46:913-922
36. Schioth HB, Phillips SR, Rudzish R, Birch-Machin MA, Wikberg JE, Rees JL 1999 Loss of function mutations of the human melanocortin 1 receptor are common and are associated with red hair. Biochem Biophys Res Commun 260:488-491
37. Schoneberg T, Schulz A, Gudermann T 2002 The structural basis of G-protein-coupled receptor function and dysfunction in human diseases. Rev Physiol Biochem Pharmacol 144:143-227
38. Cone RD 2000 Haploinsufficiency of the melanocortin-4 receptor: part of a thrifty genotype? J Clin Invest 106:185-187
39. O'Rahilly S, Farooqi IS, Yeo GS, Challis BG 2003 Minireview: human obesity - lessons from monogenic disorders. Endocrinology 144:3757-3764
40. Cummings DE, Schwartz MW 2000 Melanocortins and body weight: a tale of two receptors. Nat Genet 26:8-9
41. Gether U 2000 Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr Rev 21:90-113
42. Moro O, Lameh J, Hogger P, Sadee W 1993 Hydrophobic amino acid in the i2 loop plays a key role in receptor-G protein coupling. J Biol Chem 268: 22273-22276
43. 1b-adrenergic receptor. Involvement of basic and hydrophobic residues in receptor activation and G protein coupling. J Biol Chem 276:46485-46494
44. 1 angiotensin receptor activation and signaling. Endocrinology 144:2220-2228
45. Schumann M, Nakagawa T, Mantey SA, Tokita K, Venzon DJ, Hocart SJ, Benya RV, Jensen RT 2003 Importance of amino acids of the central portion of the second intracellular loop of the gastrin-releasing peptide receptor for phospholipase C activation, internalization, and chronic down-regulation. J Pharmacol Exp Ther 307:597-607
46. Erlenbach I, Kostenis E, Schmidt C, Serradeil-Le Gal C, Raufaste D, Dumont ME, Pausch MH, Wess J 2001 Single amino acid substitutions and deletions that alter the G protein coupling properties of the V2 vasopressin receptor identified in yeast by receptor random mutagenesis. J Biol Chem 276:29382-29392
47. Wess J 1997 G-protein-coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G-protein recognition. FASEB J 11:346-354
48. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, Yamamoto M, Miyano M 2000 Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289:739-745